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Abstract Killer-cell immunoglobulin-like receptors (KIRs)
are encoded by one of the most polymorphic families in the
human genome. KIRs are expressed on natural killer (NK)
cells, which have dual roles: (1) in fighting infection and (2)
in reproduction, regulating hemochorial placentation.
Uniquely among primates, humanKIR genes are arranged into
two haplotypic combinations: KIR A and KIR B. It has been
proposed that KIR A is specialized to fight infection, whilst
KIR B evolved to help ensure successful reproduction. Here
we demonstrate that a combination of infectious disease se-
lection and reproductive selection can drive the evolution of
KIR B-like haplotypes from a KIR A-like founder haplotype.
Continued selection to survive and to reproduce maintains a
balance between KIR A and KIR B.
Keywords Killer-cell immunoglobulin-like receptors
(KIRs) . Natural killer cells . Infectious disease .
Reproduction . Human evolution
Introduction
Killer-cell immunoglobulin-like receptors (KIRs) are
expressed on the surface of natural killer cells (NK cells)—
the major effector lymphocytes of innate immunity. Specific
KIR genotypes, genes or alleles are associatedwith differential
responses to a variety of infectious diseases (Gao et al. 2010;
Hirayasu et al. 2012; Khakoo et al. 2004; Knapp et al. 2010;
Martin et al. 2002, 2007; Seich al Basatena et al. 2011).
Furthermore, in addition to their role in fighting infection,
NK cells are involved in pregnancy. Uterine NK cells (uNK
cells) regulate how fetal placental cells remodel the spiral
arteries that supply nutrients and oxygen to the developing
feto-placental unit. In humans, maternal KIR genotype has
been shown to affect the likelihood of severe pregnancy syn-
dromes (Hiby et al. 2004, 2008, 2010; Nakimuli et al. 2015),
and birth weight itself (Hiby et al. 2014).
KIRs can be activating or inhibitory. Multiple KIR genes
are found in a 150-kb cluster on chromosome 19. Strikingly,
all human populations—even those which have experienced
extreme bottlenecks (Gendzekhadze et al. 2006)—possess
two KIR haplotypes with distinctly different gene contents.
The KIR A haplotype has largely fixed gene content, with
mostly genes encoding inhibitory KIRs; the KIR B haplotype
has a more variable gene content and contains several genes
encoding activating KIRs. Other primate species display a
high degree of KIR haplotypic diversity, but no equivalent
organisation into KIR A and KIR B-like entities (de Groot
et al. 2015; Guethlein et al. 2015). Why KIRs should have
been segregated in this way in humans, and why KIR A and
KIR B are always maintained in every human population, is an
evolutionary phenomenon demanding explanation.
One hypothesis that has been proposed is that KIR A hap-
lotypes are specialized to ensure success in fighting infection,
and KIR B haplotypes are specialized to ensure success in
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reproduction (Parham 2005, 2008; Parham andMoffett 2013).
This is in keeping with the observation that KIR A homozy-
gous individuals exhibit better clearance of hepatitis C infec-
tion (Khakoo et al. 2004), but KIR B homozygous mothers are
protected against the potentially fatal pregnancy syndrome
pre-eclampsia (Hiby et al. 2004, 2010; Nakimuli et al.
2015). However, population genetic frameworks within which
to test whether a combination of such selective pressures can
indeed promote the evolution of KIR A and KIR B haplotypes
have so far been lacking. Here, we integrate links between
KIR genotype, infectious disease and reproduction into a sin-
gle model. We demonstrate that a combination of infectious
disease selection and reproductive selection can drive the evo-
lution of both KIR A—like and KIR B-like haplotypes from a
KIR A-like ancestor.
Methods
Many KIRs have been shown to bind directly to class I major
histocompatibility complex (MHC) molecules expressed on
the surface of other cells. In humans, MHC molecules are
known as human leukocyte antigens, or HLAs. For simplicity,
we will henceforth consider only KIR/HLA interactions in-
volving HLA-C, the dominant HLA ligand for KIRs which is
present in all individuals. HLA-Cmolecules form two types of
KIR ligand, depending on the amino acid residue at position
80. These are known as C1 and C2, and a balance between
HLA-C alleles encoding C1 or C2 ligands is observed in all
human populations. In order to explore the generation of A
and B KIR haplotypes, we simulated a haplotype containing
three possible KIR genes (Fig. 1). One gene encodes a KIR
that can bind C1 (and is thus equivalent to humanKIR2DL2 or
KIR2DL3) and two genes encode KIRs that can bind C2
[equivalent to KIR2DL1 or KIR2DS1, and perhaps also
KIR2DS5*006 (Nakimuli et al. 2015)]. Mutation rates were
incorporated in the model such that (1) genes could switch
between encoding activating or inhibitory KIRs; (2) genes
could switch between being expressed or pseudogenes, and
(3) the strength (magnitude) of the inhibitory or activating
signal associated with the encoded KIR could change. In this
way, a range of possible three-gene KIR haplotypes could be
generated at random within each simulation, of varying de-
grees of similarity to those seen in human populations.
Diploid combinations of KIR haplotypes and HLA geno-
types (HLA-C1 homozygous; HLA-C2 homozygous and
HLA-C1/C2 heterozygous) were used to define individuals
in an individual-based model. Every generation, all individ-
uals had to survive infectious disease challenge, where their
probability of success was linked to their KIR/HLA genotype
(further details in the following sections). Survivors were then
randomly sampled with replacement to be the parents of the
next generation, such that a maximum of K pregnancies took
place. The success of each simulated pregnancy was deter-
mined by the combination of maternal KIR and fetal HLA
genotype (further details in the following sections), and only
surviving offspring could contribute to the next generation.
The individual-based process of first surviving infection and
then reproducing was iterated over T generations in each sim-
ulation. With each birth, came fixed probabilities of the afore-
mentioned KIR mutations or recombination (see Table 1).
Infectious disease selection
We included two types of infectious disease selection in our
simulations:
1. Selection from HLA-evading pathogens. Individuals het-
erozygous for HLA-C1 and HLA-C2 whose genome
encoded at least one expressed inhibitory KIR specific
to each of C1 and C2 were assumed to have an advantage
against pathogens which exploit particular forms of HLA-
evasion. This advantage is captured by parameter θ (see
Table 1).
2. Selection from pathogens for which the degree to which
NK cells are activated or inhibited is important. We gen-
erated, for each individual in the model, a normal distri-
bution of possible NK cell activation states derived from
their KIR/HLA genotype. In this way, the various KIR/
HLA interactions possible for a specific individual (i.e.
the different types and magnitudes of signals associated
with those interactions) could combine to generate a sin-
gle phenotype (see Electronic supplementary material
(ESM) Methods for further details We defined a range
of optimum NK cell activation states to survive infection
(xL < x < xH). The per generation probability of a given
individual dying from this type of infection was then giv-
en byμ 1−AxL ≤ x≤ xHð Þ, where AxL ≤ x≤ xH is the proportion of
that individual’s NK cell distribution that fell within the
optimum range.
The biological justifications for these assumptions were as
follows:
1. Certain viruses down-regulate MHC molecules and/or ex-
press decoy MHC molecules as a means of immune eva-
sion. In humans, inhibitory KIRs help NK cells to combat
such viruses by detecting a lack of HLA (‘missing self’).
When HLAs are present, inhibitory KIRs for which those
HLAs are ligands prevent NK cell killing. If such inhibito-
ry signals are lost, the NK cell kills the abnormal cell. In
keeping with evolutionary simulations that suggest the
presence of multiple possible inhibitory KIR-HLA ligand
pairs is advantageous against a cytomegalovirus-like
pathogen (Carrillo-Bustamante et al. 2014), we have
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assumed that HLA C1/C2 heterozygotes who express in-
hibitory KIRs that can recognise both C1 and C2, and thus
have the maximum possible number of KIR-HLA ligand
pairs protected by a missing-self mechanism in our model,
are protected against extra mortality from pathogens capa-
ble of this or similar forms of HLA-evasion.
2. KIRs differ in the relative inhibitory or activating effects
they have on NK cells (Moesta et al. 2008), and the strength
of this inhibition or activation seems to affect the possibility
of mortality. For both hepatitis C and hepatitis B, the geno-
type associated with the weakest possible inhibitory inter-
action involving HLA-C (homozygosity for KIR2DL3 and
HLA-C1) offers an increased chance of clearing the infec-
tion (Gao et al. 2010; Khakoo et al. 2004; Knapp et al.
2010). Conversely, genotypes which encode certain highly
inhibitory KIRs and their known HLA ligands are associat-
ed with delayed progression to AIDS (Martin et al. 2007).
Activating KIRs are also directly implicated in improved
responses: the activating receptor KIR3DS1 together with
its putative ligand HLA-Bw4 is associated with a delayed
progression to AIDS (Martin et al. 2002) and reduced sus-
ceptibility to opportunistic infections in individuals with
HIV (Qi et al. 2006).
Reproductive selection
We generated, for every pregnancy that occurred within each
simulation, a normal distribution of uterine NK (uNK) cell
activation states, based on the inhibition/activation signal
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Fig. 1 Hypothetical KIR haplotypes that can compete within the
model. As described in the text, we considered haplotypes consisting of
three linked KIR genes. One encodes a KIR that can bind C1 (and is thus
equivalent to human KIR2DL2 or KIR2DL3) and the other two encode
KIRs that can bind C2 [equivalent to KIR2DL1 orKIR2DS1, and perhaps
also KIR2DS5*006 (Nakimuli et al. 2015)]. For simplicity, these speci-
ficities were not allowed to mutate. Panel a shows how the most frequent
KIR A and B haplotypes observed in Caucasians would appear within our
framework. Panel b illustrates the founder haplotype used in the model
and a non-exhaustive range of possible haplotypes that could arise
through mutation within the model. Genes encoding inhibitory KIRs
are indicated in orange, genes encoding activating KIRs in blue.
Functional (expressed) genes are indicated by solid colours; non-
functional (pseudogene) genes are indicated by hashed colours. When
recombination was allowed to take place, it took place only between the
second and third loci in the cluster. This reflects the situation in humans
where recombination seems to occur most frequently between the centro-
meric region of the KIR cluster (which may contain genes encoding C1 or
C2 interacting KIRs) and the telomeric region of the KIR cluster (which
may contain a gene encoding a C2 interacting KIR).
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strengths of the KIRs encoded in the mother’s genome that
could interact with the HLA-C supplied by the father (see
ESM Methods for full details). Both excessive inhibition of
uNK cells and excessive activation of uNK cells can be risky.
The probability of the failure of a pregnancy due to excessive
inhibition of uNK cells was p:Ay≤ yT where p = the maximum
mortality rate and Ay≤ yT = the proportion of the uNK cell re-
sponse equal to or below the critical value yT. The probability of
the failure of a pregnancy due to excessive activation of uNK
cells was q:AyU ≤ y where q = the maximum risk and AyU ≤ y =
the proportion of the uNK cell response equal to or above the
critical value yU. In both cases, we assumed that the failure of a
pregnancy led to the deaths of both mother and infant.
The biological justifications for these assumptions were as
follows:
uNK cells associate closely with the developing tropho-
blast (Moffett-King 2002). KIRs expressed on uNK cells
bind to HLA-C molecules expressed by invading tropho-
blast cells, and the interaction between fetal HLA-C and
maternal KIR genotype has been shown to influence
pregnancy outcome (reviewed in Moffett and Colucci
2015). Excessive inhibition of uNK cells is a risk factor
for pregnancy disorders where placentation is poor, e.g.
pre-eclampsia, fetal growth restriction and recurrent mis-
carriage (Hiby et al. 2004, 2008, 2010, 2014; Nakimuli
et al. 2015). At the other extreme, greater activation of
uNK cells is positively correlated with higher birth
weights (Hiby et al. 2014). Paternally derived C2
expressed by the trophoblast seems to be particularly as-
sociated with these effects, hence our use of paternal
HLA-C only to define such risks in the model. It seems
that the degree of activation or inhibition of uNK cells
upon their interaction with fetal trophoblast cells has a
direct effect on the effectiveness of placentation; most
likely on the level of blood supplied through remodelled
Table 1 Parameter definitions, and how probabilities of events within the model were calculated
Item Parameter or calculation
Number of generations in simulation T
Maximum number of births per generation K
Probability of an individual dying from infection with
a pathogen for which detecting missing self is important.
θ for all individuals who are not able to express both C1 and C2 and
at least one functional inhibitory KIR recognising each, otherwise 0.
Probability of an individual dying from infection
with a pathogen for which NK cell activation state is important. μ 1−AxL ≤ x≤ xHð Þ
where μ = the maximum possible mortality rate and AxL< x< xH =
the proportion of the individual’s NK cell response that falls
within the optimum zone for surviving infection.
Probability of a pregnant female and her fetus being lost
from the population due to excessively inhibited uNK cells
p:Ay≤ yT
where p = the maximum risk and Ay≤ yT = the proportion of the
uterine NK cell response equal to or below the critical value yT.
Probability of a pregnant female and her fetus being lost
from the population due to excessively activated uNK cells
q:AyU ≤ y
where q = the maximum risk and AyU ≤ y = the proportion of the
uterine NK cell response equal to or above the critical value yU.
Per birth probability of a mutation affecting the magnitude
of the signal transmitted by the receptor encoded by
a KIR gene to NK cells in the presence of its ligand.
m1
If a mutation occurred, a value drawn from a uniform distribution
between −1 and +1 was added to the existing signal magnitude assigned
to that particular KIR in that individual’s genome. If the resulting
magnitude was <0.1, a magnitude of 0.1 was assigned.
Per birth probability of a mutation in the pseudogene
versus expressed status of any KIR gene.
m2
For simplicity there was no difference in the rate at which genes
defined as pseudogenes became expressed, or genes defined as
expressed became pseudogenes: this was a symmetrical
mutational process.
Per birth probability of a mutation in the activating or inhibitory
status of the receptor encoded by any KIR gene.
m3
For simplicity there was no difference in the rate at which genes
defined as encoding activating receptors switched to encode
inhibitory receptors, or genes defined as encoding inhibitory receptors
switched to encode activating receptors: this was a symmetrical
mutational process.
Rate at which recombination occurs between the second and
third KIR genes in the haplotype.
r
758 Immunogenetics (2016) 68:755–764
spiral arteries in the uterine wall (reviewed in Moffett and
Colucci 2015).
The importance of these observations becomes apparent
when we consider the obstetric dilemma: an evolutionary
challenge unique to modern humans. Bipedalism places
physical restrictions on the structure of the pelvis, but
encephalization (increasing brain size) demands that
babies be born with heads as large as possible. Childbirth
for Homo sapiens is therefore an exceptionally dangerous
process for both mother and baby, owing to the extremely
tight fit of the head of the fetus through the birth canal
(Wittman and Wall 2007). Given that, as we have just
discussed, the greater the level of activation of uNK cells,
the greater the birth weight, the obstetric dilemma is likely
to generate intense selective pressures on KIRs.
In our model, we assume that both excessive inhibition
and excessive activation of uNK cells are capable of kill-
ing women and fetuses during pregnancy. Pre-eclampsia,
which is clearly linked to uNK cell inhibition, can lead to
fatal eclampsia. Obstructed labour, particularly common
in humans for the reasons just outlined, is associated with
higher birth weights and therefore likely to be linked to
excessive activation of uNK cells. Obstructed labour, too,
can kill both mother and fetus, or can leave the mother
with major injuries, hence our assumption that both ex-
tremes of uNK cell inhibition and activation have the
potential to be extremely disadvantageous.
Choice of parameter values
For computational feasibility we set the maximum number of
births per generation (i.e. the maximum population size), K =
1000. In terms of the probability of a mutation arising in the
population at all, a mutation rate of 1 × 10−5 in a population of
1000 individuals is equivalent to a mutation rate of 1 × 10−7 in a
population of 100,000 individuals. Given the relatively small
population size in our simulations, for the scenarios presented
in the main text we have used relatively high mutation rates—
which made it possible for a wider range of potential KIR hap-
lotypes to emerge and compete with one another. In the ESM
Results, we show that our overall results do not depend on the
specific mutation or recombination rates applied, provided rates
are not so low that no mutations can emerge in our simulated
populations (Fig. S1).
Parameters p, q, μ and θ generate different types and
strengths of selective pressure. As such, the absolute values
of each parameter are less important than their relative values.
We seek to define which selective pressures are vital in order
to obtain a balance between KIR-A and KIR-B, not to claim
that specific values for each parameter have applied through-
out human history.
p is the maximum per-pregnancy probability of pregnancy
failure and maternal death associated with insufficiently acti-
vated uNK cells. Present-day rates of pre-eclampsia, a proxy
which will substantially underestimate parameter p because p
only applies to the most at risk genotypes, are 6.2 to 10.2 % in
American populations (Nakimuli et al. 2014). q is the maxi-
mum per-pregnancy probability of pregnancy failure and ma-
ternal death associated with excessively activated uNK cells.
Present-day rates of obstructed labour, a proxy which will
likewise underestimate parameter q, are between 3 and 6 %
(Dolea and AbouZahr 2003). Given the uncertainty in the
historical effects of pre-eclampsia and obstructed labour on
human survival, and to make sure that we explored a wide
range of possibilities, in our sensitivity analyses we tested
values of p and q between 0 and 0.4 (see ESM Results and
Fig. S2).
θ is the selection pressure from pathogens for which having
two types of HLA-C KIR ligand, both protected by a missing-
self mechanism, is an advantage. As a shorthand, we refer to
these as HLA-evading pathogens. μ is the selection pressure
from pathogens for which the degree to which NK cells are
activated or inhibited affects the survival of the host. In each
generation of the model, θ and μ define the maximum proba-
bility of dying from either type of infectious disease before
reproducing, i.e. the probability of dying for the most at risk
genotypes. Importantly, these parameters do not represent the
case fatality rates of specific pathogens: rather the overall
probability of dying from a particular sort of infectious disease
during childhood. We know from human history that specific
pathogens come and go. Smallpox, for example, is a relatively
recent burden that was only a significant cause of mortality
within the last several hundred generations; falciparummalar-
ia, similarly, seems to only have emerged within the last ten
thousand years. We can, however, be confident that infectious
diseases have plagued modern humans for as long as we have
existed. Parameters θ and μ allow our model to ask which
types of relationship between infectious diseases, KIRs and
HLAs (if any) are most likely to generate a balance between
KIR A and KIR B haplotypes. Just as for parameters p and q,
in our sensitivity analyses we allowed parameters θ and μ to
take values between 0 and 0.4, to capture a wide range of
possible selection scenarios.
Results
Selection from HLA-evading pathogens alongside
reproductive selection is essential to generate A and B like
KIR haplotypes
Our closest evolutionary relatives, chimpanzees, possess both
C1 and C2, but lack an obvious KIR A/B haplotypic structure.
Human KIR A haplotypes have more in common with
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chimpanzee KIR haplotypes than human KIR B. We thus be-
gan each simulation with balanced frequencies of C1 and C2
encoding HLA alleles and the population fixed for a KIR A-
like haplotype (Fig. 1). We sought to identify the conditions
under which a KIR B-like haplotype emerged alongside the
evolving KIR A haplotype, and the two were still maintained
together at the end of a 15,000 generation simulation. Figure 2
illustrates the time course of one of our simulations displaying
this behaviour of interest.
We found that a balanced scenario (such as illustrated in
Fig. 2), where KIR A-like and KIR B-like haplotypes and C1
and C2 are all present after 15,000 generations, was impossi-
ble to obtain without assuming some degree of selection from
HLA-evading pathogens (Fig. S2, parameter θ). Without such
selection, either C1 or C2 was likely to be lost from the pop-
ulation over the thousands of generations simulated, and with-
out a diversity of HLA ligands there was no reason tomaintain
a specific KIR haplotypic structure. So long as selection from
HLA-evading pathogens was present (θ> 0.1), the inclusion
of at least a low level of reproductive selection whereby ex-
cessive inhibition of uNK cells can cause mortality, made a
balanced scenario possible (Fig. S2 and Fig. 3a, first graph).
Selection from pathogens for which strongly inhibited NK
cells are advantageous increases the probability
of obtaining a balance between KIR A and KIR B
We found that scenarios where KIR A and KIR B coexisted
were obtained most frequently when we included not only
reproductive selection and selection from HLA-evading path-
ogens, but also selection from pathogens for which strongly
inhibited NK cells were particularly advantageous (Fig. 3a,
second graph). Without selection in favour of strongly
inhibited NK cells, the highest probability of the balanced
scenario for any single set of parameters in Fig. 3 was
14.7 %; including such selection, the highest probability of
obtaining a balanced scenario rose to 39.4 %. If strongly in-
hibitory KIRs are advantageous against certain pathogens, and
therefore maintained in the population, certain pregnancies
will experience excessive inhibition of NK cells, and suffer
associated mortalities (i.e. eclampsia). This in turn generates a
selection pressure for haplotypes containing activating KIRs,
and makes the evolution of KIR A and KIR B more likely.
Figures 3b and c compare the frequencies of KIR
AA genotypes and HLA-C2 observed in human populations
worldwide with the model’s output for two sets of parameters
where a balanced scenario is likely. Although neither of the
parameter combinations shown produce a negative correlation
as strong as that observed in human data, our model can cer-
tainly produce frequency combinations within a plausible
range.
Different types of infectious disease selection cannot
substitute for the combination of infectious disease
selection and reproductive selection
Figure 4 illustrates the contrasting selective forces acting with-
in our model in greater detail. Each of the vertical grey lines in
the figure illustrates the range of inhibitory/activating behav-
iours exhibited by functional C2 interacting KIRs in a single
simulated population after 15,000 generations of evolution.
As shown in panel 4a, a combination of selection from repro-
duction and infectious disease encourages wider ranges of
KIR-C2 interactions, from the inhibitory (negative values on
the y-axis) to the activating (positive values on the y-axis) to
coexist. It is in the regions of parameter space which allow
such a wide range of KIR-C2 interactions that KIR A and KIR
B haplotypes can emerge. If selection from infectious disease
becomes too high (the far right hand side of panel 4a), the
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Fig. 2 The emergence of KIR B alongside a founder KIR A
haplotype. Panel a illustrates the frequencies of different possible KIR
haplotypes as they evolve in a single simulation. Each KIR haplotype is
defined by its number of functional genes encoding inhibitory (‘inhib’) or
activating (‘activ’) KIRs. Mutations also occurred in the strength of
activation or inhibition associated with different allelotypes, but it is not
practical to represent all these in this figure. In the figure legend, we
identify subsets of KIR A-like and KIR B-like haplotypes, where KIR A-
like haplotypes encode at least two inhibitory KIRs and no activating
KIRs, and KIR B-like haplotypes encode at least one activating KIR.
Panel b illustrates the frequency of HLA-C2 in the same population.
Parameter values were as follows: T = 15,000; K = 1000; θ = 0.15; μ =
0.2; p = 0.26; q = 0.1; m1 = 0.001; m2 = 1 × 10−5; m3 = 1 × 10−5 and r =
0.01. The founder haplotype encoded a functional C1 interacting
inhibitory KIR with a signal magnitude of 1.5 (see ESM Methods for
further information on how inhibitory or activating signals with different
magnitudes generated by different KIRs were incorporated in the model);
a functional C2 interacting inhibitory KIR with a signal magnitude of 5,
and a pseudogene C2 interacting inhibitory KIR with a signal magnitude
of 5. The signal magnitudes for the functional C1 andC2 interactingKIRs
in the founder KIR A haplotype were chosen to reflect the observation
that, in present-day populations, KIR2DL3 + C1 has a weaker inhibitory
effect than KIR2DL1 + C2. However, all KIR signal magnitudes were
free to mutate at rate m1 (see Table 1 for further details of mutational
processes). Threshold values for the ranges of NK cell activation states
that responded best to different challenges (see Methods) were: xL = −6,
xH = −5, yT = −2 and yU = 1.
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range of evolved KIR-C2 interactions narrows to match that
which is best adapted to survive infection.
In panel 4b, we have applied no reproductive costs, but
each individual in the population must survive challenge with
pathogens for which strongly inhibited NK cells are optimal,
and pathogens for which the optimal range of NK cell
inhibition/activation is the same as that previously optimal
for reproduction. Each simulation ends up with a set of possi-
ble KIR-C2 interactions that match one or other of the opti-
mum ranges but we see none with a range of KIR-C2 interac-
tions spanning both. This result suggests that it is difficult to
create a balance between KIR A and KIR B using infectious
disease selection alone—but there are many other factors,
such as variable selection from different types of pathogens
at different stages in human history, that we have not yet
considered in our framework.
Discussion
Specific examples of trade-offs between the capacity to either
survive in the long term or maximise reproductive success in
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Fig. 3 Parameter combinations giving rise to a balance between KIR
A and KIR B. We defined a balanced scenario as one in which the
frequencies of KIR A-like and KIR B-like haplotypes (see key in
Fig. 2a) were both ≥0.1, and the frequency of HLA-C2 was >0.05 but
<0.95. Panel a illustrates the probability of obtaining this outcome for
different levels of mortality associated with excessive inhibition of uNK
cells (p, x-axis); different levels of mortality associated with excessive
activation of uNK cells (q, line colours), with or without a cost associated
with a pathogen for which the level of NK cell activation/inhibition was
important (μ, graph titles). Other parameters, the founder haplotype and
threshold values were as given in the legend to Fig. 2. One hundred and
seventy simulations were carried out at each combination of parameter
values. Panel b illustrates the frequencies of HLA-C2 and KIR A homo-
zygosity observed globally. Representative population frequencies were
taken from allelefrequencies.net (Gonzàlez-Galarza et al. 2015), see also
ESM Methods. Panel c illustrates the frequencies of HLA-C2 and KIR A
homozygosity obtained in individual simulations that were classified as
balanced. For all of panel c, p = 0.26 and μ = 0.2. The value of q is
indicated by the colour of the markers in each graph.
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the short term are rare; although one excellent recent example
is a negative association between antibody responsiveness and
reproductive success observed in Soay sheep (Graham et al.
2010). A growing collection of studies suggests that KIR
genes may be pivotal to a reproductive/immunological trade-
off in humans (Hiby et al. 2014; Khakoo and Jamil 2011;
Parham and Moffett 2013). The results presented here strong-
ly suggest that present-day population genetic patterns exhib-
ited by KIR haplotypes do indeed result from competing pres-
sures to survive infection or to reproduce successfully.
Our model identifies a combination of reproductive selec-
tion and selection from HLA-evading pathogens as critical in
allowingKIR A and B to emerge, but also shows that including
an infection survival advantage for individuals with strongly
inhibited NK cells makes a balance between A and B, along-
sideHLA alleles encoding C1 and C2 ligands, more likely. An
infection advantage associated with strongly inhibited NK
cells may follow from a process of ‘education’ or ‘licencing’
during NK cell development: specifically if stronger inhibito-
ry signals during NK cell development set up the capacity for
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Fig. 4 Range of inhibition/activation signals delivered by C2
interacting KIRs after 15,000 generations of evolution under differ-
ent conditions. In our model we classify the KIRs encoded by each
simulated haplotype both by their inhibitory or activating properties, but
also by themagnitude of the signal delivered to the NK cell. In this figure,
we classify all possible C2 interacting KIRs on a scale from highly
inhibitory (large negative values) to highly activating (large positive
values). The vertical grey lines indicate the interquartile range of all C2
interacting KIRs encoded by the haplotypes present after 15,000
generations of evolution in a given simulation. In panel a, reproductive
selection, missing-self pathogen selection and pathogen selection that
favors strongly inhibitory KIR/HLA interactions were all applied within
each simulation (parameter values as given in the legend to Fig. 2). In
panel b reproductive selection is not applied (p=0 and q=0, otherwise all
parameter values as given in the legend to Fig. 2), and in addition to
missing-self pathogen selection there were two independent challenges
from pathogens for which the level of NK cell activation/inhibition was
important. xL= -6 and xH= -5 for the first pathogen, and xL= -2 and xH= 1
for the second pathogen. Twenty simulations were carried out at each
parameter combination, but grey lines are only shown if C2 was still
present in the population after 15,000 generations. The costs associated
with pathogens for which the level of NK cell activation/inhibition was
important were varied as indicated on the x axis. At the start of each of
these simulations, all individuals in the population were assigned KIR
haplotypes generated as follows: each haplotype encoded a functional
C1 interacting inhibitory KIR with a signal magnitude of 1.5; a functional
C2 interacting inhibitory KIR with a signal magnitude randomly chosen
from 5, 4 or 3, and a pseudogene C2 interacting inhibitory KIR with a
signal magnitude randomly chosen from 5, 4 or 3.
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greater activation of NK cells during infection, as has been
proposed for certain HLA-B/KIR3DL1 combinations in HIV
patients (Martin et al. 2007). Alternatively, relatively strong in-
hibition of NK cells may help avoid immunopathologies asso-
ciated with an over-reactive immune response. A recent obser-
vation in keepingwith this hypothesis is that the relatively weak-
ly inhibitory combination of KIR2DL3 and C1 is a risk factor
for cerebral malaria, and the activating combination of
KIR2DS1 and C2 may be a risk factor for non-cerebral severe
malaria (Hirayasu et al. 2012). No infectious disease has yet
been reported for which the specific combination of alleles
encoding highly inhibitory KIR2DL1 receptors and their C2
ligands is of particular benefit. However, given the importance
of such an effect in driving the evolution of KIR A and KIR B
within our model, we predict that such a relationship should
exist for at least some of the infectious diseases with which
humans have coexisted for thousands of generations: e.g. ma-
laria or similar pathogens which cause mortality prior to repro-
duction and are able to persist in non-urban social groups.
It is important to note that our model does not require that
the best response to all pathogens involves strongly inhibited
NK cells. It has been shown that KIR B is associated with
higher IFN-γ release from NK cells upon stimulation with
mycobacteria in vitro (Portevin et al. 2012), and multiple stud-
ies of KIR genes in tuberculosis patients suggest that greater
NK cell inhibition is a risk factor for the disease (Braun et al.
2013; Mahfouz et al. 2011; Méndez et al. 2006; Shahsavar
et al. 2012) [although not every tuberculosis study has found
an effect (Tajik et al. 2012)]. It seems plausible that for some
diseases, a swift inflammatory response that eliminates infec-
tion is best, whereas for other infections, the costs to the host
of immunopathological damage are too high, and a less in-
flammatory response that nonetheless keeps the pathogen un-
der control is preferable.
Our model assumes that when responding to any specific
challenge, an individual with a narrow range of possible NK
cell behaviours that is entirely optimised for that challenge
will do better than an individual with a wider range of possible
NK cell behaviours. However, the individual with narrow NK
cell responses will, of course, perform badly against any chal-
lenge that requires NK cell responses outside of its range.
Different ranges of optimum NK cell behaviours could derive
from selection to survive infection and selection to reproduce,
or could derive from infectious disease selection alone, if—as
we have just noted—different ranges of NK cells responses
are appropriate to different pathogens.
In Fig. 4, we explored whether KIR A and B haplotypes had
to derive from a trade-off between surviving infection and re-
producing or could be driven by competing pathogen selection
pressures. Our results so far suggest that reproductive selection
per se is important in the emergence of KIR A and B. In the
presence of pathogen selection alone, a population is more
likely to evolve a strategy where all genotypes are equally good
at responding to one type of pathogen challenge, even if that
means being equally poor at responding to others (Fig. 4b). It
may be that the re-association of different HLA-C genotypes
with the mother’s existing KIR genotype that is an integral part
of the reproductive process is vital to encourage the persistence
of diverse KIR haplotypes. This reassortment means that a KIR
which happens to end up in a genotype for which the HLA-C
ligands present made it relatively unfit, will later have the
chance to encounter HLA-C ligands that render it relatively
fit (or vice versa). Such a process seems inherently likely to
encourage greater KIR diversity—and on one level the persis-
tence of KIR A and B haplotypes in all human populations can
be thought of as the persistence of a balance between diverse
(activating and inhibitory) KIRs in all human populations.
We have focused on the effect of the KIR/ HLA interaction
on NK cells. KIRs are, however, also expressed on a subset of
Tcells. It has been shown that the presence of KIR2DL2 tends
to magnify either protective or detrimental effects of certain
HLA alleles against viral infection (Seich al Basatena et al.
2011). The HLA alleles in question are not ones with which
KIR2DL2 is likely to interact directly, and the authors suggest
that the mechanism underlying their observations may involve
KIR2DL2 increasing the lifespan of certain memory Tcells. If
T cells restricted by either advantageous or disadvantageous
HLAs survive for longer in patients, their respective effects
should both tend to be enhanced. Other inhibitory KIRs may
have similar effects on the survival of T cells, and future
models including more diverse HLAs could investigate the
evolutionary significance of such a mechanism.
Recent computational studies have demonstrated that viral
expression of decoy HLA class I molecules promotes KIR
allelic diversity, and a combination of both activating and
inhibitory KIRs should offer the maximum level of protection
against such viruses (Carrillo-Bustamante et al. 2013, 2014).
It seems likely, therefore, that selection from pathogens is
responsible for the evolution of multiple KIRs, and multiple
KIR/HLA interactions, in the first instance. However, the
human-specific organisation of the KIR locus into A and B
haplotypes calls for further explanation. As we have illustrated
here, such organisation may well reflect selection from both
infectious disease and reproductive processes.
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